Charles Ballay, MD
Otolaryngology · Marrero, LANPI 1043306392
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $941 of the $1,475 with a category attached, or 63.8%. Inspire Medical Systems, Inc. accounts for 73.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,029 and has fallen 80.0% since, to $205 in 2025. That places this record below the midpoint for otolaryngology clinicians in LA, where the typical reported total is $1,485.
Across 28 payments — averaging $52.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$115
- GSK$108
- Medical Device Business Services, Inc.$40
- Cochlear Americas$37
- Stryker$29
- plus $68 from 3 others
What the payments were for
- Travel & lodging$94164%
- Food & beverage$53436%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 12 | $1,078 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| GSK | 6 | $108 |
| Medical Device Business Services, Inc. | 1 | $40 |
| Cochlear Americas | 1 | $37 |
| Stryker | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Aerin Medical Inc. | 1 | $22 |
| Sanofi | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$941
How this compares
$1,475 in reported general payments places this provider in the 45th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $54,587 |
| Azelastine Hcl | 44 | $1,136 |
| Ipratropium Bromide | 35 | $1,095 |
| CefuroximeCefuroxime Axetil | 60 | $936 |
| Levothyroxine Sodium | 121 | $711 |
| Ofloxacin | 26 | $576 |
| Gentamicin Sulfate | 14 | $546 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $381 |
| Doxycycline Hyclate | 30 | $367 |
| Cefdinir | 18 | $338 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $329 |
| Ciprofloxacin Hcl | 28 | $291 |
| Triamcinolone Acetonide | 16 | $266 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 18 | $263 |
| Montelukast Sodium | 30 | $260 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Marrero
- Adil FatakiaMarrero$148K
- Donald GonzalesNew Orleans$351K
- Kevin McLaughlinCovington$186K
- Edward McCoulNew Orleans$92K
- Michael YimShreveport$77K
- Maura CosettiShreveport$64K
- Lizabeth ClarkeNew Iberia$40K
- Henry BarhamBaton Rouge$32K
- Cherie-Ann NathanShreveport$32K
- Jesse DuplechainLafayette$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.